Poor-prognosis molecular subtypes in adenocarcinomas of pancreato-biliary and gynecological origin: A systematic review

Marjolein F. Lansbergen, Maryam Khelil, Faridi S. van Etten – Jamaludin, Maarten F. Bijlsma, Hanneke W. M. van Laarhoven

Research output: Contribution to journalReview articleAcademicpeer-review


Pancreato-biliary and gynecological adenocarcinomas need better tools to predict clinical outcome. Potential prognostic mesenchymal(-like) transcriptome-based subtypes have been identified in these cancers. In this systematic review, we include studies into molecular subtyping and summarize biological and clinical features of the subtypes within and across sites of origin, searching for suggestions to improve classification and prognostication. PubMed and Embase were searched for original research articles describing potential mesenchymal(-like) mRNA-based subtypes in pancreato-biliary or gynecological adenocarcinomas. Studies limited to supervised clustering were excluded. Fourty-four studies discussing cholangiocarcinomas, gallbladder, ampullary, pancreatic, ovarian, and endometrial adenocarcinomas were included. There was overlap in molecular and clinical features in mesenchymal(-like) subtypes across all adenocarcinomas. Approaches including microdissection were more likely to identify prognosis-associated subtypes. To conclude, molecular subtypes in pancreato-biliary and gynecological adenocarcinomas share biological and clinical characteristics. Furthermore, separation of stromal and epithelial signals should be applied in future studies of biliary and gynecological adenocarcinomas.
Original languageEnglish
Article number103982
JournalCritical Reviews in Oncology/Hematology
Publication statusPublished - 1 May 2023


  • Adenocarcinoma
  • Basal-like
  • Biliary tract
  • Gynecological
  • Mesenchymal
  • Pancreatic
  • Subtypes
  • Transcriptomic

Cite this